Atlas Trials

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

Clinical trial NCT01167049 · UNKNOWN

Trial details

NCT number
NCT01167049
Sponsor
Peking University Cancer Hospital & Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2009-08-01
Primary completion
2013-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.